Overview of Dr. Chapman-Davis
Dr. Eloise Chapman-Davis is an obstetrician/gynecologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and New York-Presbyterian Hospital. She received her medical degree from Stony Brook University Health Sciences Center School of Medicine and has been in practice 13 years. Dr. Chapman-Davis accepts several types of health insurance, listed below. She is one of 608 doctors at New York-Presbyterian Hospital and one of 608 doctors at New York-Presbyterian Hospital who specialize in Obstetrics & Gynecology. She also speaks multiple languages, including Spanish. She has more than 70 publications and over 500 citings.
Office
525 East 68th Street
Suite J-130
New York, NY 10065
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Gynecologic Oncology, 2008 - 2011
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2004 - 2008
- Stony Brook University Health Sciences Center School of MedicineClass of 2004
Certifications & Licensure
- NY State Medical License 2015 - 2025
- MA State Medical License 2013 - 2016
- IL State Medical License 2008 - 2014
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Clinical Trials
- PALS for Pap Smear Follow up Start of enrollment: 2019 Aug 22
Publications & Presentations
PubMed
- 26 citationsSynuclein-γ (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinomaJacqueline M. Morgan, Anna V. Hoekstra, Eloise Chapman-Davis, Jennifer L. Hardt, J. Julie Kim
Gynecologic Oncology. 2009-08-01 - 3 citationsLandmark Series on Disparities: Uterine Cancer and Strategies for Mitigation.Eloise Chapman-Davis, Emily M Webster, Onyinye D Balogun, Melissa K Frey, Kevin Holcomb
Annals of Surgical Oncology. 2023-01-01 - 341 citationsSingle-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian CarcinomaPanagiotis A. Konstantinopoulos, Steven E. Waggoner, Gregory A. Vidal, Monica M. Mita, John W. Moroney
JAMA Oncology. 2019-08-01
Journal Articles
- Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian CancerKristen Zeligs, Eloise Chapman-Davis, Valentin Kolev, Kevin Holcomb, American Journal of Obstetrics and Gynecology
Authored Content
- Impact of the COVID-19 Pandemic on Quality of Life for Women with Ovarian CancerJune 2020
Press Mentions
- Meyer Cancer Center Appoints Inaugural DEI Leadership TeamSeptember 12th, 2024
- Opinion: Women Don’t Have to Die from Cervical Cancer | CNNJanuary 21st, 2023
- Screening Method Frequently Misses Endometrial Cancer in Black WomenJuly 28th, 2021
- Join now to see all
Committees
- Committee Member, Tufts University School of Medicine Admission Committee 2014 - Present
Professional Memberships
- Member
- Society of Gynecologic OncologistsMember
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Coventry Health Care PPO PlatinumFirst Health PPO
Great West PPO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PHCS PPO - Kaiser
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: